Background: Little is known about placental vitamin D metabolism and its impact on maternal circulating vitamin D concentrations in humans.Objective: This study sought to advance the current understanding of placental vitamin D metabolism and its role in modulating maternal circulating vitamin D metabolites during pregnancy.Design: Nested within a feeding study, 24 healthy pregnant women (26-29 wk of gestation) consumed a single amount of vitamin D (511 IU/d from diet and a cholecalciferol supplement) for 10 wk. Concentrations of placental and blood vitamin D metabolites and placental messenger RNA (mRNA) abundance of vitamin D metabolic pathway components were quantified. In addition, cultured human trophoblasts were incubated with 13C-cholecalciferol to examine the intracellular generation and secretion of vitamin D metabolites along with the regulation of target genes. Results: In placental tissue, 25-hydroxyvitamin D3 [25(OH)D3] was strongly correlated (r = 0.83, P < 0.001) with 24,25-dihydroxyvitamin D3 Moreover, these placental metabolites were strongly correlated (r ≤ 0.85, P ≤ 0.04) with their respective metabolites in maternal circulation. Positive associations (P ≤ 0.045) were also observed between placental mRNA abundance of vitamin D metabolic components and circulating vitamin D metabolites [i.e., LDL-related protein 2 (LRP2, also known as megalin) with 25(OH)D3 and the C3 epimer of 25(OH)D3 [3-epi-25(OH)D3]; cubilin (CUBN) with 25(OH)D3; 25-hydroxylase (CYP2R1) with 3-epi-25(OH)D3; 24-hydroxylase (CYP24A1) with 25(OH)D3, 3-epi-25(OH)D3, and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]; and 1α-hydroxylase [(CYP27B1) with 3-epi-25(OH)D3 and 1,25(OH)2D3]. Notably, in vitro experiments with trophoblasts showed increased production and secretion of 25(OH)D3 and higher CYP24A1 gene transcript abundance in response to cholecalciferol treatment.Conclusions: The numerous associations of many of the placental biomarkers of vitamin D metabolism with circulating vitamin D metabolites among pregnant women [including a CYP27B1-associated increase in 1,25(OH)2D3] and the evidence of trophoblast production and secretion of vitamin D metabolites, especially 25(OH)D3, suggest that the placenta may play an active role in modulating the vitamin D metabolite profile in maternal circulation in human pregnancy. This trial was registered at clinicaltrials.gov as NCT03051867.
RCT Entities:
Background: Little is known about placental vitamin D metabolism and its impact on maternal circulating vitamin D concentrations in humans.Objective: This study sought to advance the current understanding of placental vitamin D metabolism and its role in modulating maternal circulating vitamin D metabolites during pregnancy.Design: Nested within a feeding study, 24 healthy pregnant women (26-29 wk of gestation) consumed a single amount of vitamin D (511 IU/d from diet and a cholecalciferol supplement) for 10 wk. Concentrations of placental and blood vitamin D metabolites and placental messenger RNA (mRNA) abundance of vitamin D metabolic pathway components were quantified. In addition, cultured human trophoblasts were incubated with 13C-cholecalciferol to examine the intracellular generation and secretion of vitamin D metabolites along with the regulation of target genes. Results: In placental tissue, 25-hydroxyvitamin D3 [25(OH)D3] was strongly correlated (r = 0.83, P < 0.001) with 24,25-dihydroxyvitamin D3 Moreover, these placental metabolites were strongly correlated (r ≤ 0.85, P ≤ 0.04) with their respective metabolites in maternal circulation. Positive associations (P ≤ 0.045) were also observed between placental mRNA abundance of vitamin D metabolic components and circulating vitamin D metabolites [i.e., LDL-related protein 2 (LRP2, also known as megalin) with 25(OH)D3 and the C3 epimer of 25(OH)D3 [3-epi-25(OH)D3]; cubilin (CUBN) with 25(OH)D3; 25-hydroxylase (CYP2R1) with 3-epi-25(OH)D3; 24-hydroxylase (CYP24A1) with 25(OH)D3, 3-epi-25(OH)D3, and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]; and 1α-hydroxylase [(CYP27B1) with 3-epi-25(OH)D3 and 1,25(OH)2D3]. Notably, in vitro experiments with trophoblasts showed increased production and secretion of 25(OH)D3 and higher CYP24A1 gene transcript abundance in response to cholecalciferol treatment.Conclusions: The numerous associations of many of the placental biomarkers of vitamin D metabolism with circulating vitamin D metabolites among pregnant women [including a CYP27B1-associated increase in 1,25(OH)2D3] and the evidence of trophoblast production and secretion of vitamin D metabolites, especially 25(OH)D3, suggest that the placenta may play an active role in modulating the vitamin D metabolite profile in maternal circulation in human pregnancy. This trial was registered at clinicaltrials.gov as NCT03051867.
Authors: Katie N Evans; Lisa Nguyen; Junny Chan; Barbara A Innes; Judith N Bulmer; Mark D Kilby; Martin Hewison Journal: Biol Reprod Date: 2006-09-06 Impact factor: 4.285
Authors: Martin Kaufmann; J Christopher Gallagher; Munro Peacock; Karl-Peter Schlingmann; Martin Konrad; Hector F DeLuca; Rita Sigueiro; Borja Lopez; Antonio Mourino; Miguel Maestro; René St-Arnaud; Joel S Finkelstein; Donald P Cooper; Glenville Jones Journal: J Clin Endocrinol Metab Date: 2014-03-26 Impact factor: 5.958
Authors: A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow Journal: Cell Date: 1999-02-19 Impact factor: 41.582
Authors: P A Sanchez; A Idrisa; D N Bobzom; A Airede; B W Hollis; D E Liston; D D Jones; A Dasgupta; R H Glew Journal: J Natl Med Assoc Date: 1997-12 Impact factor: 1.798
Authors: S Lundgren; T Carling; G Hjälm; C Juhlin; J Rastad; U Pihlgren; L Rask; G Akerström; P Hellman Journal: J Histochem Cytochem Date: 1997-03 Impact factor: 2.479
Authors: Folami Y Ideraabdullah; Anthony M Belenchia; Cheryl Susan Rosenfeld; Seth W Kullman; Megan Knuth; Debrata Mahapatra; Michael Bereman; Edward D Levin; Catherine Ann Peterson Journal: J Endocrinol Date: 2019-03-01 Impact factor: 4.286
Authors: Rebecca J Moon; Laura D F Cooke; Stefania D'Angelo; Elizabeth M Curtis; Philip Titcombe; Justin H Davies; Keith M Godfrey; Jane K Cleal; Rohan M Lewis; Cyrus Cooper; Nicholas C Harvey Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Debora Farias Batista Leite; Aude-Claire Morillon; Elias F Melo Júnior; Renato T Souza; Fergus P McCarthy; Ali Khashan; Philip Baker; Louise C Kenny; Jose Guilherme Cecatti Journal: BMJ Open Date: 2019-08-10 Impact factor: 2.692
Authors: Brogan Ashley; Claire Simner; Nicholas C Harvey; Jane K Cleal; Antigoni Manousopoulou; Carl Jenkinson; Felicity Hey; Jennifer M Frost; Faisal I Rezwan; Cory H White; Emma M Lofthouse; Emily Hyde; Laura D F Cooke; Sheila Barton; Pamela Mahon; Elizabeth M Curtis; Rebecca J Moon; Sarah R Crozier; Hazel M Inskip; Keith M Godfrey; John W Holloway; Cyrus Cooper; Kerry S Jones; Rohan M Lewis; Martin Hewison; Spiros D D Garbis; Miguel R Branco Journal: Elife Date: 2022-03-08 Impact factor: 8.140